Q2 2011 Investor Conference Call Presentation Charts

Science For A Better Life

Q1 2011 Investor Conference Call • Marijn Dekkers

Marijn Dekkers, CEO | July 28, 2011

Investor Conference Call

Q2 2011 Results


Q1 2011 Investor Conference Call • Marijn Dekkers •


EmergingEconomies¹

+7%

Others²+2%

USA+4%

10%

36%

34%

20%

Western Europe+6%

Q2 2011 Group sales by region

Group €9,252m; +5%

~1,300

+5%

~900

+4%

~600

+9%

~500

+14%

¹ Emerging economies include: Latin America, Asia w/o Japan, Australia,New Zealand, Africa and Middle East incl. Turkey, Eastern Europe

² Others = Japan, Australia, New Zealand, Canada³ Emerging Asia = Asia minus Japan, Australia, New Zealand

In € million, ∆% yoy Fx adjusted


Fiscal 2011 –Guidance By Subgroup

Outlook based on Fx and portfolio adj. sales and EBITDA pre-special items

HealthCareUnchanged:Low- to mid-single digit increase of sales and small increase of adj. EBITDA

PharmaUnchanged:Low- to mid-single digit increase of sales and improvement of adj. EBITDA-margin

Consumer Health Unchanged:Mid-single digit growth of sales and adj. EBITDA

CropScienceUnchanged:High-single-digit percentage higher sales and growth of adj. EBITDA by about 20% - or higher if the season progresses well in 2nd half

MaterialScience

Updated: High-single-digit percentage raise of sales. Adj. EBITDA still expected to increase at a higher rate than sales, although we regard this target as increasingly ambitious. Q3’11: Sales and adj. EBITDA in line with prior-year level

Outlook depends on specific planning assumptionsas detailed in the Q2 Quarterly Report



Marijn Dekkers, CEO | July 28, 2011

Investor Conference Call

Q2 2011 Results

Q2 2011 Investor Conference Call Presentation Charts

Business

Transcript of Q2 2011 Investor Conference Call Presentation Charts